Decrease in Mucosal IL17A, IFNγ and IL10 Expressions in Active Crohn's Disease Patients Treated with High-Dose Vitamin Alone or Combined with Infliximab.
Mia BendixAnders DigeSøren Peter JørgensenJens Frederik DahlerupBo Martin BibbyBent DeleuranJørgen AgnholtPublished in: Nutrients (2020)
High-dose vitamin D as monotherapy and combined with infliximab decreases IL17A, IFNγ and IL-10 expression in mucosa within treatment groups. This did not induce a statistically significant decreased disease activity. EudraCT no.2013-000971-34.